GeoVax Labs, Inc. (GOVX)
0.505
-0.05
(-8.60%)
USD |
NASDAQ |
Sep 03, 16:00
0.5202
+0.02
(+3.01%)
After-Hours: 18:20
GeoVax Labs Price to Book Value : 2.114 for Sept. 3, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 02, 2026 | 2.312 |
| September 01, 2026 | 2.535 |
| August 31, 2026 | 2.647 |
| August 28, 2026 | 3.018 |
| August 27, 2026 | 3.001 |
| August 26, 2026 | 2.637 |
| August 25, 2026 | 2.687 |
| August 24, 2026 | 2.872 |
| August 21, 2026 | 2.702 |
| August 20, 2026 | 2.520 |
| August 19, 2026 | 2.489 |
| August 18, 2026 | 2.723 |
| August 17, 2026 | 2.741 |
| August 14, 2026 | 3.005 |
| August 13, 2026 | 3.004 |
| August 12, 2026 | 3.037 |
| August 11, 2026 | 3.223 |
| August 10, 2026 | 3.156 |
| August 07, 2026 | 3.222 |
| August 06, 2026 | 3.018 |
| August 05, 2026 | 3.105 |
| August 04, 2026 | 3.189 |
| August 03, 2026 | 3.033 |
| July 31, 2026 | 2.851 |
| July 30, 2026 | 2.941 |
| Date | Value |
|---|---|
| July 29, 2026 | 2.922 |
| July 28, 2026 | 3.042 |
| July 27, 2026 | 3.180 |
| July 24, 2026 | 3.060 |
| July 23, 2026 | 3.516 |
| July 22, 2026 | 3.918 |
| July 21, 2026 | 4.164 |
| July 20, 2026 | 4.123 |
| July 17, 2026 | 4.077 |
| July 16, 2026 | 3.643 |
| July 15, 2026 | 4.227 |
| July 14, 2026 | 4.395 |
| July 13, 2026 | 4.646 |
| July 10, 2026 | 4.939 |
| July 09, 2026 | 4.897 |
| July 08, 2026 | 4.855 |
| July 07, 2026 | 4.981 |
| July 06, 2026 | 5.232 |
| July 02, 2026 | 4.981 |
| July 01, 2026 | 5.274 |
| June 30, 2026 | 5.315 |
| June 29, 2026 | 7.306 |
| June 26, 2026 | 7.534 |
| June 25, 2026 | 7.478 |
| June 24, 2026 | 7.877 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.54 |
| Anika Therapeutics, Inc. | 2.048 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.732 |
Price to Book Value Related Metrics
| Price | 0.505 |
| Earnings Yield | -2.76K% |
| Market Cap | 3.721M |